| Product Code: ETC7592738 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Oncology NGS Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Oncology NGS Market - Industry Life Cycle |
3.4 Iran Oncology NGS Market - Porter's Five Forces |
3.5 Iran Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Iran Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Iran Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Iran Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Iran Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Iran Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer in Iran |
4.2.2 Increasing adoption of Next-Generation Sequencing (NGS) technologies in oncology |
4.2.3 Government initiatives and investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for NGS testing in oncology |
4.3.2 High costs associated with NGS technologies and tests |
4.3.3 Lack of skilled professionals in the field of oncology NGS |
5 Iran Oncology NGS Market Trends |
6 Iran Oncology NGS Market, By Types |
6.1 Iran Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Iran Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Iran Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Iran Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Iran Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Iran Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Iran Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Iran Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Iran Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Iran Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Iran Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Iran Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Iran Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Iran Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Iran Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Iran Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Iran Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Iran Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Iran Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Iran Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Iran Oncology NGS Market Import-Export Trade Statistics |
7.1 Iran Oncology NGS Market Export to Major Countries |
7.2 Iran Oncology NGS Market Imports from Major Countries |
8 Iran Oncology NGS Market Key Performance Indicators |
8.1 Percentage increase in the number of oncology NGS tests conducted annually |
8.2 Adoption rate of NGS technologies in oncology compared to conventional methods |
8.3 Rate of research and development investments in oncology NGS technologies |
9 Iran Oncology NGS Market - Opportunity Assessment |
9.1 Iran Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Iran Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Iran Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Iran Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Iran Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Iran Oncology NGS Market - Competitive Landscape |
10.1 Iran Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Iran Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here